BD PharmingenTM Alexa FluorTM 647 Biosimilar Anti-Human CD20

Description

Flow cytometric analysis of Human CD20 Obinutuzumab Biosimilar expression on Human peripheral blood lymphocytes. Human whole blood was stained with PE Mouse Anti-Human CD19 antibody Cat. No. 555413 and with either Alexa Fluor 647 IgG1, kappa N297A Human Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD20 Obinutuzumab antibody Cat. No. 570530/570531; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD20 or Ig Isotype control staining versus CD19 was derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometric analysis was performed using a BD Fortessa X-20 Flow Cytometer System and FlowJo Software. Flow cytometric analysis of Human CD20 Obinutuzumab Biosimilar expression on Human peripheral blood leukocytes. Human whole blood was stained with either Alexa Fluor 647 IgG1, kappa N297A Human Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD20 Obinutuzumab antibody Cat. No. 570530/570531; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD20 or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocyte populations. Flow cytometric analysis was performed using a BD Fortessa X-20 Flow Cytometer System and FlowJo Software. Flow cytometric analysis of Human CD20 Obinutuzumab Biosimilar expression on Human peripheral blood lymphocytes. Human whole blood was stained with PE Mouse Anti-Human CD19 antibody Cat. No. 555413 and with either Alexa Fluor 647 IgG1, kappa N297A Human Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD20 Obinutuzumab antibody Cat. No. 570530/570531; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD20 or Ig Isotype control staining versus CD19 was derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometric analysis was performed using a BD Fortessa X-20 Flow Cytometer System and FlowJo Software. Show More Flow cytometric analysis of Human CD20 Obinutuzumab Biosimilar expression on Human peripheral blood leukocytes. Human whole blood was stained with either Alexa Fluor 647 IgG1, kappa N297A Human Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD20 Obinutuzumab antibody Cat. No. 570530/570531; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD20 or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocyte populations. Flow cytometric analysis was performed using a BD Fortessa X-20 Flow Cytometer System and FlowJo Software. Show More Flow cytometric analysis of Human CD20 Obinutuzumab Biosimilar expression on Human peripheral blood lymphocytes. Human whole blood was stained with PE Mouse Anti-Human CD19 antibody Cat. No. 555413 and with either Alexa Fluor 647 IgG1, kappa N297A Human Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD20 Obinutuzumab antibody Cat. No. 570530/570531; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD20 or Ig Isotype control staining versus CD19 was derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometric analysis was performed using a BD Fortessa X-20 Flow Cytometer System and FlowJo Software. Flow cytometric analysis of Human CD20 Obinutuzumab Biosimilar expression on Human peripheral blood leukocytes. Human whole blood was stained with either Alexa Fluor 647 IgG1, kappa N297A Human Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD20 Obinutuzumab antibody Cat. No. 570530/570531; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD20 or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocyte populations. Flow cytometric analysis was performed using a BD Fortessa X-20 Flow Cytometer System and FlowJo Software.